Literature DB >> 24356791

Encapsulation status of papillary thyroid microcarcinomas is associated with the risk of lymph node metastases and tumor multifocality.

K Cupisti1, N Lehwald1, M Anlauf2, J Riemer2, T A Werner1, A Krieg1, J Witte1, A Chanab1, S E Baldus2, M Krausch1, A Raffel1, C Herdter1, M Schott3, W T Knoefel1.   

Abstract

The management of papillary microcarcinoma (PMC) of the thyroid is controversial, especially after partial thyroid resection for benign thyroid disease. In order to detect prognostic factors for PMC, we analyzed 116 patients with PMC for encapsulation status and lymph node metastases. Between 10/1992 and 12/2010, 116 patients with PMC have been operated in our department (87 females, 29 males, median age 49 years). Eighty per cent of PMCs were diagnosed postoperatively. Seventy-six patients (66%) received a more extended resection with either thyroidectomy, near total thyroidectomy, or Dunhill operation either primarily or after completion operation, whereas 40 patients (34%) had only partial resection. Fifty patients (43%) received radioiodine (RIA) ablation. Lymph node metastases were found in 21 patients (18%). Univariate analysis showed four risk factors to be significantly associated with the risk of lymph node metastasis (p<0.05): male gender, younger age, age group<50 years and nonencapsulation of the tumor. Multivariate analysis demonstrated statistical significance for gender and tumor capsulation status. The tumor capsulation status also correlated with tumor multifocality. Our data show that the risk of lymph node metastases is significantly higher in partially or nonencapsulated PMC than in encapsulated specimens. We therefore suggest that the WHO classification should be extended to a compulsory notification of the encapsulation status in PMC. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24356791     DOI: 10.1055/s-0033-1361158

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


  4 in total

1.  Risk Factors for Contralateral Occult Papillary Thyroid Carcinoma in Patients with Clinical Unilateral Papillary Thyroid Carcinoma: A Case-Control Study.

Authors:  Liu Yihao; Li Shuo; Xi Pu; Wang Zipeng; Sun Hanlin; Chang Qungang; Wang Yongfei; Yin Detao
Journal:  Int J Endocrinol       Date:  2022-06-28       Impact factor: 2.803

2.  Clinicopathological and Prognostic Value of Survivin Expression in Surgically Resected Pancreatic Ductal Adenocarcinoma.

Authors:  Christian Vay; Shahrooz Babaei; Sami-Alexander Safi; Levent Dizdar; Alexander Rehders; Lena Haeberle; Christoph Roderburg; Sven H Loosen; Irene Esposito; Wolfram T Knoefel; Andreas Krieg
Journal:  Cancers (Basel)       Date:  2022-07-18       Impact factor: 6.575

3.  Capsular Invasion Matters Also in "Papillary Patterned" Tumors: A Study on 121 Cases of Encapsulated Conventional Variant of Papillary Thyroid Carcinoma.

Authors:  Dilara Akbulut; Ezgi Dicle Kuz; Nazmiye Kursun; Serpil Dizbay Sak
Journal:  Endocr Pathol       Date:  2021-01-04       Impact factor: 3.943

4.  Survivin and XIAP: two valuable biomarkers in medullary thyroid carcinoma.

Authors:  Thomas A Werner; Yasemin Tamkan-Ölcek; Levent Dizdar; Jasmin C Riemer; Achim Wolf; Kenko Cupisti; Pablo E Verde; Wolfram T Knoefel; Andreas Krieg
Journal:  Br J Cancer       Date:  2016-02-04       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.